Clinical and immunological differences between early and late-onset myasthenia gravis in Japan

Journal of Neuroimmunology

Volumn 230, Issue 1-2, 2011, Pages 148-152

  Suzuki, Shigeaki ^a   Utsugisawa, Kimiaki ^b   Nagane, Yuriko ^b   Satoh, Takashi ^a   Kuwana, Masataka ^a   Suzuki, Norihiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hanamaki General Hospital   (Japan)

Author keywords

Autoantibody; HLA; Late onset; Myasthenia gravis

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; HLA DR ANTIGEN; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; PROTEIN ANTIBODY; TITIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; ONSET AGE; PRIORITY JOURNAL; SEROLOGY; THYMOMA;

AGE OF ONSET; AGED; AUTOANTIBODIES; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; JAPAN; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEVERITY OF ILLNESS INDEX;

EID: 78650987466     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.10.023     Document Type: Article

References (17)

1. Aarli J.A. Myasthenia gravis in the elderly: is it different? Ann. NY Acad. Sci. 2008, 1132:238-243.
2. Alshekhlee A., Miles J.D., Katirji B., Preston D.C., Kaminski H.J. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 2009, 72:1548-1554.
3. Evoli A., Minisci C., Di Schino C., Marsili F., Punzi C., Batocchi A.P., Tonali P.A., Doglietto G.B., Granone P., Trodella L., Cassano A., Lauriola L. Thymoma in patients with MG: characteristics and long-term outcome. Neurology 2002, 59:1844-1850.
4. Heldal A.T., Owe J.F., Gilhus N.E., Romi F. Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology 2009, 73:150-151.
5. Jaretzki A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., Sanders D.B. Myasthenia gravis: recommendations for clinical research standards. Task Force Med. Sci. Advis. Board Myasthenia Gravis Found. America. Neurol. 2000, 55:16-23.
6. Matsui N., Nakane S., Nakagawa Y., Kondo K., Mitsui T., Matsumoto T., Arisawa K., Kaji R. Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan. J. Neurol. Neurosurg. Psychiatry 2009, 80:1168-1171.
7. Matsuki K., Juji T., Tokunaga K., Takamizawa M., Maeda H., Soda M., Nomura Y., Segawa M. HLA antigens in Japanese patients with myasthenia gravis. J. Clin. Invest. 1990, 86:392-399.
8. Meriggioli M.N., Sanders D.B. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009, 8:475-490.
9. Murai H., Yamashita H., Nomura Y., Yoshikawa, Watanabe H.M., Kira J. National epidemiological survey of myasthenia gravis in Japan. Abstr. 61st Annu. Meet. Am. Acad. Neurol. 2009, 2009.
10. Niks E.H., Kuks J.B., Roep B.O., Haasnoot G.W., Verduijn W., Ballieux B.E., De Baets M.H., Vincent A., Verschuuren J.J. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5. Neurology 2006, 66:1772-1774.
11. Romi F., Skeie G.O., Gilhus N.E., Aarli J.A. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch. Neurol. 2005, 62:442-446.
12. Shinomiya N., Nomura Y., Segawa M. A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan. Clin. Immunol. 2004, 110:154-158.
13. Somnier F.E. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology 2005, 65:928-930.
14. Suzuki S., Utsugisawa K., Nagane Y., Satoh T., Terayama Y., Suzuki N., Kuwana M. Classification of myasthenia gravis based on autoantibody status. Arch. Neurol. 2007, 64:1121-1124.
15. Wirtz P.W., Willcox N., van der Slik A.R., Lang B., Maddison P., Koeleman B.P., Giphart M.J., Wintzen A.R., Roep B.O., Verschuuren J.J. HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome. J. Neuroimmunol. 2005, 159:230-237.
16. Yeh J.H., Chen W.H., Chiu H.C., Vincent A. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese. Neurology 2004, 62:2131-2132.
17. Zhang X., Yang M., Xu J., Zhang M., Lang B., Wang W., Vincent A. Clinical and serological study of myasthenia gravis in HuBei Province, China. J. Neurol. Neurosurg. Psychiatry 2007, 78:386-390.